Literature DB >> 3302083

The aetiology of Crohn's disease.

G N Tytgat, C J Mulder.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3302083     DOI： 10.1007/BF01648449

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN： 0179-1958            Impact factor:   2.571


× No keyword cloud information.
  49 in total

1.  C3 metabolism in ulcerative colitis and Crohn's disease.

Authors:  H J Hodgson; B J Potter; D P Jewell
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

2.  Bacterial L-form isolation from inflammatory bowel disease patients.

Authors:  M R Belsheim; R Z Darwish; W C Watson; B Schieven
Journal:  Gastroenterology       Date:  1983-08       Impact factor: 22.682

3.  Selected bacterial antibodies in Crohn's disease and ulcerative colitis.

Authors:  I O Auer; A Röder; F Wensinck; J P van de Merwe; H Schmidt
Journal:  Scand J Gastroenterol       Date:  1983-03       Impact factor: 2.423

4.  Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.

Authors:  I O Auer; A Röder; J Fröhlich
Journal:  Gastroenterology       Date:  1984-06       Impact factor: 22.682

5.  Familial prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease.

Authors:  J F Mayberry; J Rhodes; R G Newcombe
Journal:  Br Med J       Date:  1980-01-12

6.  A possible role of Eubacterium and Peptostreptococcus species in the aetiology of Crohn's disease.

Authors:  J P van de Merwe; G J Mol
Journal:  Antonie Van Leeuwenhoek       Date:  1980       Impact factor: 2.271

7.  Ankylosing spondylitis and inflammatory bowel disease. I. Prevalence of inflammatory bowel disease in patients suffering from ankylosing spondylitis.

Authors:  S G Meuwissen; B J Dekker-Saeys; D Agenant; G N Tytgat
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

8.  Acute viral enteritis and exacerbations of inflammatory bowel disease.

Authors:  R L Gebhard; H B Greenberg; N Singh; P Henry; H L Sharp; L Kaplan; A Z Kapikian
Journal:  Gastroenterology       Date:  1982-12       Impact factor: 22.682

9.  Spontaneous suppressor cell activity in the peripheral blood of patients with malignant and chronic inflammatory bowel diseases.

Authors:  K Doldi; B Manger; B Koch; J Riemann; P Hermanek; J R Kalden
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

10.  Familial incidence of Crohn's disease in The Netherlands and a review of the literature.

Authors:  I T Weterman; A S Peña
Journal:  Gastroenterology       Date:  1984-03       Impact factor: 22.682
View more
  5 in total

Review 1.  Mycobacteria and Crohn's disease.

Authors:  S J Hampson; J J McFadden; J Hermon-Taylor
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

2.  Controlled trial of anti-tuberculous chemotherapy for two years in Crohn's disease.

Authors:  G L Swift; E D Srivastava; R Stone; R D Pullan; R G Newcombe; J Rhodes; S Wilkinson; P Rhodes; G Roberts; B W Lawrie
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

3.  Significance of systemic endotoxaemia in inflammatory bowel disease.

Authors:  K R Gardiner; M I Halliday; G R Barclay; L Milne; D Brown; S Stephens; R J Maxwell; B J Rowlands
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

Review 4.  Crohn's disease and the mycobacterioses: a review and comparison of two disease entities.

Authors:  R J Chiodini
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

5.  Antibodies to Mycobacterium paratuberculosis in patients with Crohn's disease.

Authors:  F Brunello; A Pera; S Martini; L Marino; M Astegiano; C Barletti; P Gastaldi; G Verme; G Emanuelli
Journal:  Dig Dis Sci       Date:  1991-12       Impact factor: 3.199
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.